AgilentWeb_191022_WebHeader_Logo_v2

Separation Science, in collaboration with
Agilent, offers an expert presentation and discussion event in which experts discuss their approaches to the challenges of glycosylation analysis, focused on biotherapeutics and biomarkers.

Date: 19 & 20 October, 2022

Start Times:
Broadcast #1: 19 October - starting at 10 am EDT (New York) / 3 pm BST (London) / 4 pm CEST (Paris).
Broadcast #2: 19 October - starting at 11 am PDT (Los Angeles) / 1 pm CDT (Chicago) / 2 pm EDT (New York).
Broadcast #3: 20 October - starting at 8.30 am IST (Mumbai) / 11 am SGT (Singapore) / 12 pm JST (Tokyo)/ 1 pm AEST (Sydney) / 3 pm NZST (Auckland).

Duration: Approximately 75 minutes

Presenters & Panellists:

ArnaudDelobel_200Arnaud Delobel
R&D and Innovation Director, Quality Assistance S.A.

 

PaulineRudd_200Pauline Rudd
Professor at BTI AStar Singapore, GCon consultancy

 

GordanLauc_200Gordan Lauc
Founder and CEO of Genos & CSO at GlycanAge

 

MichaelButler_200Michael Butler
Principal Investigator in Cell Technology at NIBRT

 

JamesDuffy_200James Duffy
Assay Development Manager - MS, LabCorp

 

Moderator

MikeClaybourn_200Mike Claybourn
Independent Pharmaceutical Consultant

 


Sponsor:

Agilent_Logo_RGB

 

   

DE36677284

Event Overview

Glycosylation – the addition of sugar molecules to proteins – is a post-translational modification that can profoundly influence protein structure and function. Historically, glycan analysis (or glycomics) has lagged behind genomics and proteomics in terms of prominence and technology development. This is beginning to change as a growing audience becomes aware of the criticality of protein glycosylation. With this change, biopharmaceutical researchers who understand robust and reproducible ways to analyze glycosylation in their samples can increase confidence in their results, and potentially reduce costly efforts later in the development cycle.

In this event we bring together industry leaders who will present their approaches to the challenges of glycosylation analysis, focused on biotherapeutics and biomarkers. This will include an introductory scene-setting presentation followed by an expert discussion with participants providing their insights into current trends in glycan analysis, key analytical challenges facing the industry, and future directions in the field.

By attending this educational event you will:

  • hear from leading scientists on current approaches to N-glycan and sialic acid analysis
  • learn about current methods for glycan analysis of biotherapeutics by liquid chromatography/ mass spectrometry (LC/MS)
  • understand the challenges facing biopharmaceutical scientists in terms of both analytical quality and regulatory issues
  • hear about some of the unmet needs and what is required to move this key field forwards


Why not participate in this expert discussion with industry leaders – air or submit your questions, and learn from others, on other areas of glycan analysis. You can submit your questions in advance using the registration form to the right.

 

To register for this upcoming event please complete the form on the right. 

Registrants to this webinar are covered by the Eclipse Business Media Privacy Policy. Information you provide will be shared with the sponsors for this content. Eclipse Business Media Ltd may contact you to offer you content based on your specific interests. You may opt-out at any time.